Meltzer Lisa J, Mindell Jodi A, Owens Judith A, Byars Kelly C
Department of Pediatrics, Children's Hospital of Philadelphia, 3535 Market St, Philadelphia, PA 19104, USA.
Pediatrics. 2007 Jun;119(6):1047-55. doi: 10.1542/peds.2006-2773.
Little is known about the medications prescribed for sleep in hospitalized children. The aims of this study were to (1) determine the percentage of hospitalized children who receive medication for sleep disturbances, (2) determine what medications are prescribed for sleep difficulties, and (3) examine medical and demographic variables related to medications prescribed during hospitalization.
A chart review was conducted for all inpatients at 3 pediatric hospitals across 26 randomly selected days in 2004. Demographic, medical, and medication data were collected on 9440 patients. The sample was 54.5% male, had a mean age of 7.0 years, and was 63% white. Almost 19% of the patients had at least 1 psychiatric diagnosis.
Overall, 6.0% of all hospitalized children (3% of all medically hospitalized children, excluding children with a psychiatric diagnosis) were prescribed medications for sleep, with antihistamines the most frequently prescribed medication (36.6%), followed by benzodiazepines (19.4%); hypnotic agents were the least frequently prescribed (2.2%). Significant differences were found in both the frequency of sleep-medication prescriptions and the types of medications used across hospitals, as well as for age, length of hospitalization, and service that the child was discharged from. Children with a psychiatric diagnosis were more likely to receive a sleep medication, with 22% of children on a psychiatric service receiving a sleep-related medication.
Approximately 3% to 6% of children are treated pharmacologically with a broad array of sleep medications in hospital settings. Prescription practices vary by hospital, medical service, child age, and diagnosis. The results from this study indicate that medications are being prescribed for sleep in hospitalized children, especially in children with psychiatric diagnoses. However, given that there are neither Food and Drug Administration-approved sleep medications for children nor clinical consensus guidelines regarding their use, clinical trials, practice guidelines, and additional research are clearly needed.
对于住院儿童所开具的助眠药物了解甚少。本研究的目的是:(1)确定因睡眠障碍而接受药物治疗的住院儿童的比例;(2)确定针对睡眠困难所开具的药物;(3)检查与住院期间所开药物相关的医学和人口统计学变量。
2004年在26个随机选定的日子里,对3家儿科医院的所有住院患者进行了病历审查。收集了9440名患者的人口统计学、医学和用药数据。样本中男性占54.5%,平均年龄为7.0岁,63%为白人。近19%的患者至少有1项精神科诊断。
总体而言,所有住院儿童中有6.0%(所有内科住院儿童的3%,不包括有精神科诊断的儿童)被开具了助眠药物,其中抗组胺药是最常开具的药物(36.6%),其次是苯二氮䓬类药物(19.4%);催眠药开具得最少(2.2%)。在不同医院之间,以及在儿童的年龄、住院时间和出院科室方面,助眠药物处方的频率和所用药物类型均存在显著差异。有精神科诊断的儿童更有可能接受助眠药物治疗,在精神科科室的儿童中有22%接受了与睡眠相关的药物治疗。
在医院环境中,约3%至6%的儿童接受了多种助眠药物的药物治疗。处方做法因医院、医疗科室、儿童年龄和诊断而异。本研究结果表明,住院儿童尤其是有精神科诊断的儿童正在被开具助眠药物。然而,鉴于既没有美国食品药品监督管理局批准的儿童助眠药物,也没有关于其使用的临床共识指南,显然需要进行临床试验、制定实践指南并开展更多研究。